PLUS1
13.64
0.76 (5.9%)
0.76 (5.9%)
Upgrade to Real-Time
Afterhours (Closed)
| Volume | 1,297,839 |
|
|||||
| News | - | ||||||
| Day High | 13.76 | Low High |
|||||
| Day Low | 12.85 | ||||||
| Stock Name | Stock Symbol | Market | Stock Type |
|---|---|---|---|
| Altimmune Inc | ALT | NASDAQ | Common Stock |
| Price Change | Price Change % | Stock Price | Last Trade
|
|
|---|---|---|---|---|
| 0.76 | 5.9% | 13.64 | 11:40:28 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 12.93 | 12.85 | 13.76 | 13.64 | 12.88 |
| Trades | Stocks Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 12,990 | 1,297,839 | US$ 13.36 | US$ 17,342,341 | - | 3.83 - 23.49 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 11:53:09 | 1 | US$ 13.63 | USD |
Period:
Draw Mode:
Altimmune Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| US$ 670.53M | 49.16M | 48.77M | US$ 4.41M | US$ - | -2.35 | -7.00 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | US$ - | - | -29.02k | 10.20% |
Altimmune News
| Date | Time | Source | News Article |
|---|---|---|---|
| 11/1/2023 | 00:01 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) |
| 05/1/2023 | 08:06 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 04/1/2023 | 23:30 | GlobeNewswire Inc. | Altimmune Announces Oral Presentation of Pemvidutide.. |
| 23/12/2022 | 08:06 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 20/12/2022 | 23:00 | GlobeNewswire Inc. | Altimmune Announces Positive Topline Results from 24-Week.. |
| 06/12/2022 | 05:45 | TipRanks | Altimmune (ALT) Gets a Buy from JMP Securities |
| 02/12/2022 | 09:15 | TipRanks | B.Riley Financial Remains a Buy on Altimmune (ALT) |
| 02/12/2022 | 08:06 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 22/11/2022 | 23:30 | GlobeNewswire Inc. | Altimmune to Participate at Two Upcoming Investor.. |
| 11/11/2022 | 08:16 | Edgar (US Regulatory) | Quarterly Report (10-q) |
| 10/11/2022 | 23:07 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 10/11/2022 | 23:00 | GlobeNewswire Inc. | Altimmune Announces Third Quarter 2022 Financial Results and.. |
Historical ALT Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 14.58 | 15.06 | 12.30 | 13.55 | 1,869,443 | -0.94 | -6.45% |
| 1 Month | 16.55 | 17.17 | 12.30 | 14.55 | 1,373,956 | -2.91 | -17.58% |
| 3 Months | 11.62 | 17.17 | 8.29 | 12.64 | 1,483,199 | 2.02 | 17.38% |
| 6 Months | 12.01 | 23.49 | 8.29 | 14.00 | 1,977,937 | 1.63 | 13.57% |
| 1 Year | 7.41 | 23.49 | 3.83 | 11.93 | 1,564,413 | 6.23 | 84.08% |
| 3 Years | 1.76 | 35.10 | 1.60 | 13.01 | 1,831,031 | 11.88 | 675.0% |
| 5 Years | 1.83 | 36.25 | 0.245 | 11.07 | 1,366,689 | 11.81 | 645.36% |